The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, clinical activity, and PD-L1 expression of avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic urothelial carcinoma from the JAVELIN Solid Tumor phase Ib trial.
 
Andrea B. Apolo
No Relationships to Disclose
 
Jeffrey R. Infante
Consulting or Advisory Role - EMD Serono (Inst)
Research Funding - EMD Serono (Inst)
 
Omid Hamid
Consulting or Advisory Role - Merck
Research Funding - Merck (Inst)
 
Manish R. Patel
No Relationships to Disclose
 
Ding Wang
No Relationships to Disclose
 
Karen Kelly
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech; Lilly; Synta; Transgene
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Encore Clinical (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Proacta (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech; Lilly; Synta; Transgene
 
Anthony E. Mega
Honoraria - Bayer; Sanofi
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer; Sanofi
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Bayer; Medivation/Astellas; Sanofi
 
Carolyn D. Britten
Research Funding - Amgen (Inst); Apogee Biotechnology Corporation (Inst); Bayer (Inst); Boston Biomedical (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
 
Alain C. Mita
No Relationships to Disclose
 
Alain Ravaud
No Relationships to Disclose
 
Jean-Marie Cuillerot
Employment - EMD Serono
 
Anja von Heydebreck
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology